chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Issues were similar to what I have experienced with the flu vaccine but a bit more pronounced including soreness at the injection site (moderate), tiredness (moderate),  joint pain (moderate), headache (mild). The worst of the symptoms started on the first day post-vaccine and subsided about 36 hours later.
This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a certified medical assistant concerning a 15 months old patient who on 01-MAY-2007 was vaccinated with a 0.65 ml dose of Zostavax (Merck) instead of dose of Varivax. A product quality complaint was not involved. Additional information has been requested.
On day 4 after second shot, I had headaches and nusea which lastes for several days.
This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), NASOPHARYNGITIS (Feels like a cold) and PYREXIA (Had a little temperature) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 013L20) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer, Chronic respiratory disease, Wheezy bronchitis and Knee pain. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (WIXELA INHUB) from June 2021 to an unknown date for Chronic respiratory disease, ALBUTEROL SULFATE, HYDROCHLOROTHIAZIDE, ROSUVASTATIN, POTASSIUM CHLORIDE, ASPIRIN [ACETYLSALICYLIC ACID], VITAMIN D [VITAMIN D NOS], DOCUSATE SODIUM (COLACE), LEVOTHYROXINE, MELOXICAM, VARICELLA ZOSTER VACCINE, LORATADINE, OMEPRAZOLE and MACROGOL 3350 (MIRALAX) for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Oct-2021, the patient experienced DYSPNOEA (Difficulty breathing) and NASOPHARYNGITIS (Feels like a cold). On an unknown date, the patient experienced PYREXIA (Had a little temperature). At the time of the report, DYSPNOEA (Difficulty breathing), NASOPHARYNGITIS (Feels like a cold) and PYREXIA (Had a little temperature) outcome was unknown.            As concomitant medication the patient is using eye drops as needed and water pill. For chronic respiratory condition the patient was taking medicine.   The patient mentioned that they were experiencing difficulty breathing after being at a wedding with a lot of people and air conditioning.  No treatment information was provided by the reporter.
This spontaneous report as received from Licensed Practical Nurse refers to an unspecified number of patients of unknown age and gender. Since 17-NOV-2014 (exact date unspecified) those patients were vaccinated with an improperly stored dose of ZOSTAVAX (strength, route of administration, dose and lot # were not reported. The reporter was not able to provided a cumulative time from of these excursions, so the total time out of range was not known at the time of the report. Follow-up information has been received from a Licensed Practical Nurse on 15-DEC-2014. The reporter stated that two patients received ZOSTAVAX one male and one female. This report concerns a female patient of unknown demographics. On an unknown date, a female patient received a dose of ZOSTAVAX (lot# J016259, expiry date: 27-FEB-2015, dose, units, route od administration, anatomical location were not reported) which was improperly stored. There had been no reported adverse events since administration and there was no need for revaccination. This is one of several reports received from the same reporter. Additional information has been requested.
Patient presented to the ED on 4/2/21 and 5/9/21. Patient presented to the ED and was subsequently hospitalized on 4/16/21. These visits are within 6 weeks of receiving COVID vaccination.
This case was reported by a healthcare professional and described the occurrence of localized inflammatory reaction in a 10-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). Concurrent vaccination given on 27 June 2008 included VARIVAX; Merck; unknown. Concurrent medications included ALBUTEROL. On 27 June 2008 at 10:30, the subject inadvertently received an adult dose of HAVRIX (1 ml, unknown, right arm), instead of the intended 1st dose of pediatric HAVRIX. This was considered to be an accident overdose. Follow-up information was received on 15 July 2008 via a healthcare professional, who reported that a physician ordered a pediatric dose of HAVRIX for the infant subject. After the subject left the clinic, the healthcare professional stated that she realized that the subject had accidentally been administered an adult dose of HAVRIX. The healthcare professional immediately notified the physician of the error and contacted a pharmacy and GlaxoSmithKline to inform them of possible implications. In addition, the healthcare professional informed the subject's mother of unspecified studies and advised her to monitor the infant for increased symptoms if fever and/or inflammatory reactions occurred. The healthcare professional indicated that the subject experienced a local inflammatory reaction at an unspecified time after vaccination with adult HAVRIX, and recommended treatment with TYLENOL or MOTRIN. The healthcare professional indicated that the immunization series was neither discontinued nor delayed, stating that the subject was scheduled to receive the 2nd dose of pediatric HAVRIX in six months. At the time of reporting the events were resolved.
SWOLLEN CALVES AND FEET; FEELING HOT AT CALVES AND FEET; HEARTBURN; ABOUT A 5/10 PAIN OVER EYES; 8/10 PAIN; TIGHTNESS ON CHEST; CHEST PAIN; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 12-AUG-2021, the patient experienced swollen calves and feet. On 12-AUG-2021, the patient experienced feeling hot at calves and feet. On 12-AUG-2021, the patient experienced heartburn. On 12-AUG-2021, the patient experienced about a 5/10 pain over eyes. On 12-AUG-2021, the patient experienced 8/10 pain. On 12-AUG-2021, the patient experienced tightness on chest. On 12-AUG-2021, the patient experienced chest pain. On 12-AUG-2021, the patient experienced headache. Laboratory data included: Pain scale (NR: not provided) 5/10 PAIN OVER EYES, 8/10 PAIN. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, swollen calves and feet, feeling hot at calves and feet, heartburn, about a 5/10 pain over eyes, 8/10 pain, tightness on chest, and chest pain. This report was non-serious.
Was brought in by mom; noted that left deltoid area has been swelling, hot to touch and with redness noted 12 hours post vaccination.
With first vaccine on 07/07/2021- The next day on 07/08/2021 was achy, 7/09/2021 I felt pain in my legs, back of leg burning around 12:30pm, I worked from home that day and went to lay down, an hour later I tied to stand and I almost fell, was unable to stand, feet tingling, I spoke with the nurse and was instructed to go to ER. Went to ER- They diagnosed me with piriform syndrome, it had to do with sciatic nerve, they gave me pain shots but I still felt pain, was able to leave ER an that is when they prescribed me Norco. I talked to PCP and he ordered MRI an X-rays, received epidural on 07/15/2021. I still had no movement. Got second shot 07/28/2021, had redness in my arm, that night I had diarrhea, got 2nd epidural on 08/03/2021. I have a little movement but still unable to stand for any amount of time past 3 to 4 minutes, still have tingling in feet, pain on side, all of this is on right side. Hard to sit for long periods. I use walker and crutches. I may be having surgery, but am currently in the covid backlog to get that surgery, ETA 3 to 4 months.
Hep B shot - started to have breathing problems and seizure-like activity, drawing her hands up and shaking head. Was admitted to hospital, discharged Saturday. Never drew blood at hospital, only there one night for observation.
Had my 2nd COVID vaccination shot at 2 pm on Monday, January 11, 2021.    Next morning - moderate pain in upper left arm/shoulder (place of injection). Working full shift.    Around 4 pm on Tuesday (after almost 3hrs OR case) - feeling very tired. Completed the working shift at 6 pm. Minor to moderate headache started to develop later in the evening. Two pills of Tylenol at 9 pm, another two around 2 am - while headache was getting worse.  @6:30 am Wednesday - informed managers that I'll have to stay off work because of bad headache (7 to 8 from 10), called EH as well.    During the day - mostly staying in the bed. Tylenol, water, tea with lemon, apples for hydration. Headache -- up and down (between 4 and 8), occasional fatigue and nausea (after staying upright more than 10-15 minutes), left upper arm pain, moderate pain in joints (knees, hips, low back). No fever.   Troubled night-time sleeping because of headache. 7 am - informed managers and EH about my condition, Got approval for another day off - with request to have a C-Test after that. Similar feeling and treatment.    Slow improvement during the day. Around 5 pm - feeling good enough to start moving more actively, headache and shoulder pain on low level, though getting tired quickly still.    Much better sleeping. No symptoms in the morning. Had a COVID test before returning to work.
no adverse event; A patient at the pharmacy received said vaccine after the expiration date of 06-Feb-2023 on the date of 08-Feb-2023.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A patient at the pharmacy received said vaccine after the expiration date of 06-Feb-2023 on the date of 08-Feb-2023.) and NO ADVERSE EVENT (no adverse event) in an 18-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 057A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 08-Feb-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Feb-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (A patient at the pharmacy received said vaccine after the expiration date of 06-Feb-2023 on the date of 08-Feb-2023.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A patient at the pharmacy received said vaccine after the expiration date of 06-Feb-2023 on the date of 08-Feb-2023.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (A patient at the pharmacy received said vaccine after the expiration date of 06-Feb-2023 on the date of 08-Feb-2023.).    No concomitant product reported by the reporter. No signs or symptoms were noticed after vaccination. No treatment medication reported by the reporter.
large local rxn; 16DEC94 f/u: swelling & soreness @ inj site; treated w/ice & DPH;
Patient was given DTaP and IPV, IM L Deltoid on 31Mar08.  Patient returned to clinic on 02Apr08 with C/O swelling, redness, and pain to L deltoid. No fever noted. Patient dx w/cellulitis to L deltoid and Tx'd w/Abx (Clindamycin).
PT DESCRIBES IMMEDIATE PAIN UPON INJECTION. "FELT HIGHER UP ON ARM THAN NORMAL". DAYS FOLLOWING INJECTION PT EXPERIENCED MORE PAIN THAN WITH PREVIOUS VACCINES AND LIMITED MOBILITY. PT STATES SHE DID BEST TO KEEP ARM MOBILE AND EVENTUALLY PAIN/MOBILITY HAS IMPROVED.  PT STATES SHE STILL HAS "NERVE PAIN" THAT RADIATES TO ELBOW AREA ON AFFECTED ARM. PT DID NOT SEEK ANY MEDICAL CARE TO DATE. ADVISED TO DO SO IF PAIN CONTINUES.
Patient describes his experience as a "loss of vision" shortly followed by "blanking out" and dropping his phone. Patients in the observation area noticed him fainting and called pharmacy staff over to the location. Patient experienced no issues breathing nor experienced any swelling. Patient describes quickly feeling better, though pulse showed 60 BPM once EMS arrived.
02/20/2013 Mother noticed a lump on client's right thigh the middle of this week (02/20/13). Today it is the size of a pea, not red in color, and bothers the client upon palpation of the bump. Mother has given client TYLENOL. Encouraged to speak with doctor on Monday if mother is still concerned.
pt recv vax & that evening began feeling exhausted temp 102 cont to run temp today;has contacted MD regarding sx states had similar rxn w/last Td 20yr ago;
This spontaneous report was received from a nurse concerning a patient of unknown age and gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On 04-JAN-2016, the patient was vaccinated with a dose of GARDASIL lot # K016966 and expiration date of 10-MAY-2017, for prophylaxis (dose and route of administration were not reported). On 06-FEB-2017, the patient was vaccinated with a dose of GARDASIL 9 lot # M009378 and expiration date of 23-APR-2018, for prophylaxis (dose and route of administration were not reported). This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1802USA013791: US-009507513-1803USA003340.
Insomnia; Fatigue; Nausea; Vomiting; Chills; Headache; Diarrhea; Back Pain; Extreme Stomach Cramps; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Insomnia), ABDOMINAL PAIN UPPER (Extreme Stomach Cramps), DIARRHOEA (Diarrhea), BACK PAIN (Back Pain) and FATIGUE (Fatigue) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (Extreme Stomach Cramps). On 02-Apr-2021, the patient experienced DIARRHOEA (Diarrhea), BACK PAIN (Back Pain), NAUSEA (Nausea), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache). On 04-Apr-2021, the patient experienced INSOMNIA (Insomnia) and FATIGUE (Fatigue). On 04-Apr-2021, ABDOMINAL PAIN UPPER (Extreme Stomach Cramps), DIARRHOEA (Diarrhea) and NAUSEA (Nausea) had resolved. On 05-Apr-2021, BACK PAIN (Back Pain), VOMITING (Vomiting), CHILLS (Chills) and HEADACHE (Headache) had resolved. At the time of the report, INSOMNIA (Insomnia) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
The morning following the vax, the pt had pain in left arm muscle "shooting" to her heart and shoulder blade. 2 hours later complained of weakness and tachycardia. Went to the ER. 1st EKG was ok, but experienced some problems later and there was an irregularity. Discharged home with no further problems, aside from soreness and knot at injection site.
body aches; fatigue; headache; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body aches), VACCINATION SITE PAIN (Pain at the injection site), FATIGUE (fatigue) and HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Immunocompromised.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 16-Jan-2021, the patient experienced PAIN (body aches), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, PAIN (body aches), VACCINATION SITE PAIN (Pain at the injection site), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided Treatment medications were not provided   This case was linked to MOD-2022-465342 (Patient Link).
Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.; The vaccine was administered to about 9 to 10 patients before the excursion error was discovered; vaccine expired by 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 008C21A and 008C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day). At the time of the report, PRODUCT STORAGE ERROR (Vaccine administered to about 9 to 10 patients after being stored in refrigerator for 31 days.), PRODUCT TEMPERATURE EXCURSION ISSUE (The vaccine was administered to about 9 to 10 patients before the excursion error was discovered) and EXPIRED PRODUCT ADMINISTERED (vaccine expired by 1 day) had resolved.            No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-207778 (Patient Link).
Fever within 12 hours of shot.. told by dr's office to admin childrens fever medicine and i did so.  some inflamation at the shot site on arm.. i don't remember which shot was administered there..   after that he started to loose his words and vocabulary.. started to get detached.. and hyper around the house.. unable to concentrate,etc.. he has been now diagnosed with pdd nos..   he was a developing normally until this set of the 4 shots!
sore arm, but not sore enough that patient could not sleep on her left side; brief headache; extremely short lived drop in body temperature; This is a spontaneous report received from a contactable reporter (Consumer). The reporter is the patient.  A 71 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 02Feb2021 (Lot number: EL 3249) as dose 1, single for Covid-19 immunisation. Relevant medical history included: "Chronic kidney disease", start date: 2012 (unspecified if ongoing), notes: stage 2a chronic kidney disease; "Ringing in ears" (unspecified if ongoing); "allergic grass" (unspecified if ongoing); "animal dander allergy" (unspecified if ongoing); "mold allergy" (unspecified if ongoing); "fabrics allergy" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN C [ASCORBIC ACID]; STOOL SOFTENER; CALCIUM;VITAMIN D NOS. Past drug history included: Sulfa, reaction(s): "tongue enlarged to enormous proportions". The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Feb2021, outcome "unknown", described as "sore arm, but not sore enough that patient could not sleep on her left side"; HEADACHE (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "brief headache"; BODY TEMPERATURE DECREASED (non-serious) with onset Feb2021, outcome "recovered" (Feb2021), described as "extremely short lived drop in body temperature". Relevant laboratory tests and procedures are available in the appropriate section. Additional Information: Patient feel so much safer after having the vaccine. Patient got tested twice for nasal swabs, once before patient visited her son for the first time and once when patient started to experience a ringing in her ears, both tests were negative. Patient has been good about social distancing and using safety protocols, although patient does her own grocery shopping. Patient is taking unspecified multivitamin. Patient doesn't know if she had an allergic to any ingredient in the vaccine but just wanted to report her experience. Patient stated if she needs a booster shot in the future, she is not sure if she will be willing to get it or if she really need to get the booster hopefully it is less of a dose for her and may be just as effective.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021444925 same patient/drug, different dose and event
About 7 hours after her injection she noticed a knot developed and pain at the base of her neck.  It was the same side as the injection.  She described the pain and knot as the same as she was feeling in her shoulder from the shot.  Today she says the pain is resolved, however the knot is still mildly present.  She did not seek medical treatment.
Woke up day after receiving the shot with fever, stomach ache, swelling and hot site of shot, unstable to walk easily including some dizziness and weakness. Normal mobility is good. Had some sweating and shivering with fatigue. These symptoms continued the next day also. On day three after shot day I woke up feeling normal except arm was still a little sore and swollen.
p/ recv vax in 1996 pt in 1998 devel breakthrough chickenpox w/approx 500 lesions. tests done on pt for analysis
Within 90 seconds of vaccine had sweats, room spinning, ringing in ears, head ache. The days following had tight chest, diarrhea, vomiting, head ache fullness of ears, extreme body aches, fever, tight chest, ringing in ears. Most symptoms cleared within 14 days tight chest cleared within 6 months. Ringing in ears has continued and has not shown any improvement.
Moderna COVID-19 vaccine administered after beyond-use-date and time from the refrigerator (17.5 hours past)
J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 2/24/2023 ACUTE ON CHRONIC RESPIRATORY FAILURE J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 2/24/2023 ACUTE RENAL FAILURE, UNSPECIFIED J96.20 ACUTE ON CHRONIC RESPIRATORY FAILURE 2/24/2023 CHRONIC HEPATITIS B
Information has been received from a registered nurse concerning a 4 year old male patient with an egg allergy who was vaccinated with a dose of MMR (lot # unavailable) by another health care provider. According to the patient's mother, the patient developed a runny nose and sinus congestion that lasted 3 months after he was vaccinated. Follow up information was received from a registered nurse. It was noted that the patient was also vaccinated with a dose of influenza virus vaccine (unspecified) (manufacturer unknown). According to the reporter, the patient's mother stated that the patient had "symptoms persisting for months after receiving a flu and MMR injection" a the pediatrician's office. It was reported that the patient had recovered. Additional information is not expected.
Patient c/o "flushing" from site of injection (RD, IM) to fingers and to neck/face area.